Voxmind | $735,203 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
XCENA | $135,000,000 | (Jun 2, 2026)
Certified by Founder
Lodge
GRO Biosciences
start up
United States
- Boston, MA
- 23/07/2024
- Series B
- $60,300,000
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
- Industry Pharmaceutical Manufacturing
- Website https://grobio.com/
- LinkedIn https://www.linkedin.com/company/grobio/
Related People
Dan MandellCo Founder
United States -
Boston, Massachusetts
Expanding the amino acid alphabet to make better medicines. Experienced Chief Executive Officer and scientist with a demonstrated history of technology development. Strong business development professional skilled in Computational Biology, Protein Chemistry, Entrepreneurship, Molecular Biology, and Metabolic Engineering.
Inherent | $50,000,000 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
Handshake(UK) | $3,200,000 | (Jun 2, 2026)
Sekai(US) | $26,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
Perceptic | $12,000,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
MokN | $15,000,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)